Showing posts with label associated. Show all posts
Showing posts with label associated. Show all posts

Saturday, September 10, 2011

Researchers identify genetic mutations associated with diseases of the esophagus

ScienceDaily (July 26, 2011) — Mutations in three genes have been identified that are more prevalent in patients with esophageal cancer and Barrett esophagus, a premalignant metaplasia (change in cells or tissue) caused by chronic gastroesophageal reflux disease (GERD), according to preliminary research reported in the July 27 issue of JAMA.See Also:Health & MedicineGenesBrain TumorParkinson's ResearchDiseases and ConditionsGastrointestinal ProblemsPersonalized MedicineReferenceTumor suppressor geneBRCA1BRCA2Tumor

The incidence of esophageal adenocarcinoma (EAC) in the United States and Europe has increased 350 percent since 1970, with the cause uncertain. Esophageal adenocarcinoma is believed to be preceded by Barrett esophagus (BE), according to background information in the article. Barrett esophagus is common, estimated to occur in 1 percent to 10 percent of the general population. "Finding predisposition genes may improve premorbid risk assessment, genetic counseling, and management," the authors write.

Charis Eng, M.D., Ph.D., of the Cleveland Clinic, and colleagues conducted a study to identify a gene or genes associated with BE/EAC predisposition. The research included an analyses of 21 concordant (both)-affected sibling pairs with BE/EAC and 11 discordant sibling pairs (2005-2006). The study also included data from 176 white patients with BE/EAC and 200 ancestry-matched controls (2007-2010). Data from 19 BE/EAC tissues yielded 12 "priority" candidate genes for mutation analysis. Genes that showed mutations in cases but not in controls were further screened in 58 cases.

Analyses indicated that three major genes, MSR1, ASCC1, and CTHRC1 were associated with BE/EAC. Mutational analyses of the 12 priority candidate genes in BE/EAC cases found mutations in these three genes in 13 of 116 patients (11.2 percent), with the most frequently mutated being MSR1 (approximately 7 percent), followed by ASCCl and CTHRC1. "Findings of germline

Tuesday, August 30, 2011

Optimism associated with lower risk of having stroke

ScienceDaily (July 22, 2011) — A positive outlook on life might lower your risk of having a stroke, according to new research reported in Stroke: Journal of the American Heart Association.See Also:Health & MedicineStroke PreventionHeart DiseaseElder CareMind & BrainCaregivingStrokeBrain InjuryLiving WellReferenceMulti-infarct dementiaHormone replacement therapyHigh density lipoproteinBrain damage

In an observational study, a nationally representative group of 6,044 adults over age 50 rated their optimism levels on a 16-point scale. Each point increase in optimism corresponded to a 9 percent decrease in acute stroke risk over a two-year follow-up period.

"Our work suggests that people who expect the best things in life actively take steps to promote health," said Eric Kim, study lead author and a clinical psychology doctoral student at the University of Michigan.

Optimism is the expectation that more good things, rather than bad, will happen.

Previous research has shown that an optimistic attitude is associated with better heart health outcomes and enhanced immune-system functioning, among other positive effects.

The study is the first to discover a correlation between optimism and stroke. Previous research has shown that low pessimism and temporary positive emotions are linked to lower stroke risk. Researchers analyzed self-reported stroke and psychological data from the ongoing Health and Retirement Study, collected between 2006 and 2008. Participants were stroke-free at the beginning of the study.

Researchers measured optimism levels with the modified Life Orientation Test-Revised, a widely used assessment tool in which participants rank their responses on a numeric scale.

The team used logistic regression analysis to establish the association between optimism and stroke and adjusted for factors that might affect stroke risk, including chronic illness, self-reported health and sociodemographic, behavioral, biological and psychological conditions.

"Optimism seems to have a swift impact on stroke," said Kim, noting that researchers followed participants for only two years. The protective effect of optimism may primarily be due to behavioral choices that people make, such as taking vitamins, eating a healthy diet and exercising, researchers said. However, some evidence suggests positive thinking might have a strictly biological impact as well.

Stroke is the No. 3 killer in the United States, behind heart disease and cancer, and a leading cause of disability.

Co-authors of the study are Nansook Park, Ph.D., and Christopher Peterson, Ph.D. Author disclosures are on the manuscript.

The Robert Wood Johnson Foundation's Pioneer Portfolio funded a part of the study through the Positive Psychology Center of the University of Pennsylvania.

Email or share this story:

Tuesday, August 23, 2011

Medicare Part D associated with reduction in nondrug medical spending

ScienceDaily (July 26, 2011) — Among elderly Medicare beneficiaries with limited prior drug coverage, implementation of Medicare Part D was associated with significant reductions in nondrug medical spending, such as for inpatient and skilled nursing facility care, according to a study in the July 27 issue of JAMA.See Also:Health & MedicinePharmacologyToday's HealthcareHealth PolicyPersonalized MedicineHIV and AIDSControlled SubstancesReferencePalliative carePharmaceutical companyDetoxClinical trial

"Implementation of the Medicare prescription drug benefit (Part D) in January 2006 was followed by increased medication use, reduced out-of-pocket costs, and improved adherence to essential medications for elderly persons. The effects of Part D on nondrug medical spending for Medicare beneficiaries have not been clearly defined," according to background information in the article.

J. Michael McWilliams, M.D., Ph.D., of Harvard Medical School and Brigham and Women's Hospital, Boston, and colleagues compared nondrug medical spending for traditional Medicare beneficiaries before and after the implementation of Part D. Nationally representative survey data and linked Medicare claims from 2004-2007 were used to compare nondrug medical spending before and after the implementation of Part D by self-reported generosity of prescription drug coverage (extent to which medications were mostly or completely covered) before 2006. Participants included 6,001 elderly Medicare beneficiaries from the Health and Retirement Study, including 2,538 with generous and 3,463 with limited drug coverage before 2006.

Adjusted total nondrug medical spending before implementation of Part D was consistently but not significantly higher for participants with limited drug coverage than for participants with generous drug coverage (7.6 percent relative difference). The researchers found that nondrug medical spending after Part D implementation was 3.9 percent lower for participants with limited prior drug coverage than for those with generous prior drug coverage, which was a significant differential